HKSH Medical Group
↗Happy Valley, Hong Kong
HKSH Medical Group is a leading private healthcare provider in Hong Kong, established to promote public health and advanced medicine through a multi-faceted approach encompassing clinical services, medical education, and scientific research. The group is solely owned by The Li Shu Fan Medical Foundation and operates under a not-for-profit model, where surplus revenues are reinvested into medical technology, facilities, and education.
The group's flagship members include the Hong Kong Sanatorium & Hospital (founded in 1922), HKSH Healthcare, HKSH Eastern Medical Centre, and the HKSH Cancer Centre. It is recognized for introducing cutting-edge medical technologies to Asia, such as the region's first MRI-guided radiation therapy (MR-LINAC) and Hong Kong's first proton therapy system. HKSH is also the first private hospital in Hong Kong to receive National Medical Products Administration (NMPA) accreditation for clinical trials in oncology.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Healthcare Services
Sub-Industry:Hospitals & Clinical Research
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$500M-$1B
Founded:2015
Ownership:private
Status:operating
FUNDING
Investors:The Li Shu Fan Medical Foundation
PIPELINE
Stage:Commercial
Lead Drug Stage:Phase 2/3 (Clinical Trial Site)
Modalities:Proton Therapy, MR-Guided Radiotherapy, Cell therapy (CAR-T), Nuclear Medicine, Precision Medicine
Active Trials:25
Trial Phases:Phase 1: 5 | Phase 2: 10 | Phase 3: 8 | Phase 4: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:The Li Shu Fan Medical Foundation
Subsidiaries:Hong Kong Sanatorium & Hospital, HKSH Healthcare, HKSH Eastern Medical Centre, HKSH Cancer Centre
Key Partnerships:UCLA Health (Oncology training and knowledge transfer), United Imaging (AI-powered imaging innovation), National Cancer Center, Beijing (Proton therapy training), HKUST (Medical school development and research), The University of Hong Kong (Clinical teaching and research)
COMPETITION
Position:Leader
Competitors:Gleneagles Hong Kong Hospital, Matilda International Hospital, Hong Kong Adventist Hospital, CUHK Medical Centre, St. Paul's Hospital
LEADERSHIP
Key Executives:
Dr. Walton Li - CEO & Medical Superintendent
Mr. Wyman Li - Chief Operating Officer
Dr. Joseph Chan - Chief Medical Officer
Scientific Founders:Dr. Li Shu Fan (Founder (Historical))
Board Members:Dr. Tsao Yen Chow (Chairman, Management Committee), Prof. Sophia Chan (External Member, IIPD Governance), Dr. Moses Cheng (External Member, IIPD Governance)
LINKS
Website:hksh.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with HKSH Medical Group. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.